中信证券股份有限公司 关于哈尔滨敷尔佳科技股份有限公司 2025年度持续督导培训情况报告 深圳证券交易所： 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为哈尔滨敷尔 佳科技股份有限公司（以下简称"敷尔佳"或"公司"）首次公开发行股票并在创业 板上市的保荐人，根据《深圳证券交易所上市公司自律监管指引第 13 号——保 荐业务》的相关规定，对敷尔佳进行了 2025 年度持续督导培训，报告如下： 一、本次持续督导培训的基本情况 （一）保荐人：中信证券股份有限公司 （七）培训对象：公司控股股东及实际控制人、董事、高级管理人员、部分 中层以上管理人员及证券事务代表等相关人员 三、本次持续督导培训的结论 保荐人按照《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》 的有关要求，对敷尔佳进行了 2025 年度持续督导培训。 1 （二）保荐代表人：鄢凯红、范新亮 （三）协办人：陈溪峪 （四）培训时间：2025 年 11 月 19 日 （五）培训地点：公司会议室 （六）培训人员：鄢凯红 （八）培训内容：本次培训主要介绍 2025 年以来新修订法规主要修订内容， 并重点介绍《上市公司治理准则》修订内容及 ...

Core Viewpoint - The cosmetics sector experienced a 1.6% increase on November 27, with Keshare leading the gains, while the overall market showed mixed results with the Shanghai Composite Index rising by 0.29% and the Shenzhen Component Index declining by 0.25% [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3875.26, up 0.29% [1] - The Shenzhen Component Index closed at 12875.19, down 0.25% [1] - The cosmetics sector's individual stock performance is detailed in a table, highlighting significant gainers such as Keshare with a 9.12% increase [1] Group 2: Individual Stock Performance - Keshare (300856) closed at 16.15 with a 9.12% increase and a trading volume of 310,700 shares, amounting to a transaction value of 489 million yuan [1] - Marubi Biological (603983) closed at 35.19, up 4.89%, with a trading volume of 87,200 shares and a transaction value of 304 million yuan [1] - Other notable performers include Water Sheep (300740) with a 2.72% increase and a transaction value of 580 million yuan [1] Group 3: Capital Flow Analysis - The cosmetics sector saw a net outflow of 25.34 million yuan from institutional investors and 82.57 million yuan from retail investors, while individual investors contributed a net inflow of 108 million yuan [2] - A detailed table shows the capital flow for individual stocks, indicating that LaFang (603630) had a net inflow of 5.96 million yuan from institutional investors [3] - Other stocks like Shanghai Jahwa (600315) and Huaye Fragrance (300886) also experienced varying degrees of net inflow and outflow from different investor categories [3]

Market Overview - The cosmetics sector experienced a decline of 1.1% on November 26, with Kesheng Co. leading the drop [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] Individual Stock Performance - Notable gainers included: - Shuiyang Co. (300740) with a closing price of 19.85, up 2.58% [1] - Fulejia (301371) also rose by 2.58% to 27.88 [1] - Major decliners included: - Kesheng Co. (300856) fell by 4.88% to 14.80 [2] - Marubi Bio (603983) decreased by 2.95% to 33.55 [2] - Jiahen Home (300955) dropped by 2.85% to 37.84 [2] Trading Volume and Capital Flow - The cosmetics sector saw a net inflow of 7.95 million yuan from institutional investors, while retail investors contributed a net inflow of 7.35 million yuan [2] - However, there was a net outflow of 15.30 million yuan from speculative funds [2] Detailed Capital Flow Analysis - Key stocks with significant capital flow: - Jiahen Home (300955) had a net inflow of 18.65 million yuan from institutional investors, but a net outflow of 19.54 million yuan from retail investors [3] - Fulejia (301371) saw a net inflow of 12.12 million yuan from speculative funds, despite a net outflow from retail investors [3] - Other stocks like Qingdao King (002094) and Shanghai Jahwa (600315) also experienced mixed capital flows, indicating varied investor sentiment [3]

Core Points - The stock price of Shiyijia (敷尔佳) has decreased by 2.48%, closing at 27.18 yuan [1] - Shiyijia was listed on the Shenzhen Stock Exchange's ChiNext board on August 1, 2023, with an initial share price of 55.68 yuan and a total issuance of 40.08 million shares [1][2] - The stock reached a peak price of 80.04 yuan on its first trading day but is currently in a state of decline [2] Fundraising and Financials - Shiyijia raised a total of 223.17 million yuan through its initial public offering (IPO), with a net amount of 207.18 million yuan, exceeding the original plan by 17.52 million yuan [2] - The company planned to raise 189.66 million yuan for projects including production base construction, R&D and quality testing center, brand marketing, and working capital [2] - The total issuance costs (excluding VAT) amounted to 15.99 million yuan, with underwriting fees of 10.75 million yuan [2] Dividend Distribution - According to the announcement for the 2024 annual equity distribution, Shiyijia plans to distribute cash dividends of 10 yuan per 10 shares (including tax) to shareholders, totaling 400.08 million yuan [2] - Additionally, the company will increase its capital by issuing 3 new shares for every 10 shares held, resulting in a total of 120.02 million new shares, raising the total share capital to 520.10 million shares [2]

Investment Rating - The report does not explicitly state an investment rating for the industry or companies involved [5][6]. Core Insights - The 13th Committee's 8th Plenary Session successfully passed the "14th Five-Year Plan" development proposal, emphasizing the transformation direction of "five changes and one advancement" to convert various advantages into development momentum [5][11]. - The focus during the "14th Five-Year" period will be on four major directions to accelerate the construction of a new highland for opening up to the north, including deepening cooperation with Russia and expanding into diverse markets [12]. - The Black龙江板块 index experienced a significant adjustment, dropping 2.63% in November, with a notable decline of 7.31% from November 17 to 21, indicating a bearish market sentiment [21][24]. Summary by Sections Economic Development - The "14th Five-Year" plan outlines 15 parts and 62 articles, detailing development tasks across three major sectors, aiming for a modernized strong province [5][11]. - The province aims to enhance its international economic cooperation and optimize the foreign investment environment, promoting the "Investment Longjiang" brand [12]. Market Performance - The Black龙江板块 index has shown a downward trend, with only five companies achieving positive returns during the period from November 10 to 21, with People's Tongtai leading at a 37.59% increase [21][25]. - The overall performance of the listed companies was weak, with 23 companies experiencing declines of over 5%, and 8 companies seeing declines exceeding 10% [21][25]. Industry Insights - The report highlights the importance of collaboration with companies like UBTECH to enhance talent cultivation and industrial upgrading in the province, focusing on the application of humanoid robots in education [15]. - The province's economic data for the first three quarters of the year indicates a stable growth trend, supported by strong import and export performance [21].

Group 1 - The medical sector showed signs of recovery, with major player United Imaging Healthcare rising over 3%, while other stocks like WuXi AppTec and Aier Eye Hospital fell more than 1% [1] - The largest medical ETF in A-shares (512170) experienced a decline of over 2.8% in the morning but recovered slightly in the afternoon, ultimately dropping over 1%, marking a four-month low [1] - A-shares' three major indices collectively fell over 2% [1] Group 2 - The medical ETF (512170) fell below its six-month moving average and approached a critical yearly support level, with significant trading volume of over 874 million yuan, setting a new monthly high for daily trading [3] - In the first four trading days of the week, over 627 million yuan flowed into the ETF, indicating potential bottom-fishing activity despite the risk of larger sell-offs [3] - The medical ETF has a current scale exceeding 25.3 billion yuan, making it the largest medical-related ETF in the market, with a focus on "medical devices + medical services" [3][4] Group 3 - The ETF's composition includes a significant weighting of over 26% in CXO, along with leading companies in aesthetic medicine, private hospitals, and medical information technology [3] - The ETF is passively tracking the CSI Medical Index, which was established on December 31, 2004, and published on October 31, 2014 [4]

Core Viewpoint - The company Fulejia experienced a decline in stock price and trading volume, with significant changes in financing and shareholding structure, indicating potential challenges in revenue and profit generation [1][2][3]. Financing and Trading Activity - On November 20, Fulejia's stock dropped by 4.58%, with a trading volume of 234 million yuan. The financing buy-in amounted to 28.92 million yuan, while financing repayment was 26.48 million yuan, resulting in a net financing buy of 2.44 million yuan. The total financing and margin balance reached 116 million yuan [1]. - The current financing balance of 115 million yuan represents 5.34% of the circulating market value, which is below the 30th percentile level over the past year, indicating a low financing level [1]. - In terms of margin trading, Fulejia repaid 100 shares and sold 500 shares on November 20, with a selling amount of 13,400 yuan. The margin balance stood at 458,600 yuan, exceeding the 80th percentile level over the past year, indicating a high margin level [1]. Company Performance - For the period from January to September 2025, Fulejia reported a revenue of 1.297 billion yuan, a year-on-year decrease of 11.54%. The net profit attributable to shareholders was 325 million yuan, down 36.73% year-on-year [2]. - Since its A-share listing, Fulejia has distributed a total of 1 billion yuan in dividends [3]. Shareholding Structure - As of November 10, Fulejia had 14,900 shareholders, an increase of 0.69% from the previous period. The average number of circulating shares per shareholder decreased by 0.68% to 5,192 shares [2]. - Among the top ten circulating shareholders, notable changes include a decrease in holdings by major ETFs, with Huabao Zhongzheng Medical ETF reducing its stake by 317,500 shares, and new entry by Hong Kong Central Clearing Limited holding 462,800 shares [3].

Market Overview - The cosmetics sector experienced a decline of 2.85% on November 20, with Bavi Co. leading the drop [1] - The Shanghai Composite Index closed at 3931.05, down 0.4%, while the Shenzhen Component Index closed at 12980.82, down 0.76% [1] Individual Stock Performance - Jiahen Home Cosmetics (300955) closed at 38.29, up 1.48% with a trading volume of 27,300 shares and a turnover of 103 million yuan [1] - Bavi Co. (920123) saw a significant drop of 9.28%, closing at 17.89 with a trading volume of 88,500 shares and a turnover of 163 million yuan [2] - Qingdao Kingway (002094) closed at 7.69, down 2.16%, with a trading volume of 214,700 shares and a turnover of 166 million yuan [1][2] Capital Flow Analysis - The cosmetics sector experienced a net outflow of 377 million yuan from institutional investors, while retail investors saw a net inflow of 323 million yuan [2] - The main capital inflow and outflow for various stocks indicate a mixed sentiment, with some stocks like Jiahen Home Cosmetics seeing a net inflow of 9.93 million yuan from institutional investors [3] Notable Stock Movements - Fuleida (600223) had a net outflow of 25.36 million yuan from institutional investors, but a net inflow of 9.99 million yuan from retail investors [3] - Kesheng Co. (300856) experienced a net outflow of 29.14 million yuan from institutional investors, while retail investors contributed a net inflow of 12.29 million yuan [3]

Market Overview - The cosmetics sector increased by 1.72% on November 19, with Keshare leading the gains [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Key Performers - Keshare (300856) closed at 15.29, up 7.98% with a trading volume of 315,500 shares and a turnover of 475 million yuan [1] - Bavi (920123) closed at 19.72, up 4.89% with a trading volume of 118,600 shares and a turnover of 229 million yuan [1] - Lafang (603630) closed at 24.60, up 4.15% with a trading volume of 145,700 shares and a turnover of 353 million yuan [1] - Other notable performers include Shuiyang (300740) and Tian Cai Ya (603605), with increases of 3.28% and 2.55% respectively [1] Fund Flow Analysis - The cosmetics sector saw a net inflow of 201 million yuan from institutional investors, while retail investors experienced a net outflow of 252 million yuan [2] - Keshare had a net inflow of 63.71 million yuan from institutional investors, while retail investors had a net outflow of 47.79 million yuan [3] - Other companies like Shuiyang and Furuida also experienced significant net inflows from institutional investors, indicating strong interest in the sector [3]

Core Viewpoint - The stock prices of several companies, including Kesh Holdings, Bawei Holdings, and Yiyi Holdings, have seen significant increases, indicating positive market sentiment and potential investment opportunities in these firms [1] Company Performance - Kesh Holdings experienced a stock price increase of over 10% [1] - Bawei Holdings and Yiyi Holdings both saw their stock prices rise by more than 5% [1] - Other companies such as Shuiyang Holdings, Huaye Fragrance, Polaier, and Fulejia also showed upward trends in their stock prices [1]